Defense Daily Network
Login | Subscribe
Advanced Search
Army Navy-USMC Air Force Congress Business Homeland International Space Financial  

May 14, 2008

Emergent BioSolutions Acquires VaxGen's Anthrax Vaccine Technology

Full Issue | Comments | Print | Email | Archives | Copyright Permissions |

Emergent BioSolutions [EBS] has acquired the assets and rights to a recombinant protective antigen (rPA) anthrax vaccine product candidate and related technology from VaxGen, Inc. [VXGN] for $2 million plus a potential additional $8 million in milestone...

Username:
Password:
 
Log in Help

Also in this Issue
AUSA
Defense Daily Insider
Article Archives
DoD Budgets
Weapons Spotlight
 Document Drawer
RDDS

Tool Box
Events & Webinars
Media Kit 		Job Center
Publications & Reports
Defense Job Center
FEATURED EMPLOYER
Defense Information System Agency

Post a job listing
Post an Anonymous Resume
View All Jobs
Defense Daily Books
The Perfect Storm: Security Clearance Delays & Aging Workforce Issues in Defense 

Safeguarding Facilities in a Time of Terrorism

Money & the Military

Overcoming the Military Oil Addiction

Combating the IED Challenge

Defense Industry Globalization: The All-American Arsenal of Democracy Disappears
Defense Daily
04:39 PM
Navy League Hosts Wounded Warriors at Army-Navy Game
04:31 PM
NASA Deputy Administrator Dale to Resign On January 17
04:30 PM
General Dynamics Board Declares Dividend
 
Defense Daily Insider
–
Gates Plans 'Hard Look' At Pentagon Procurement System Under New Administration
–
Pentagon Eyeing $1.5 Billion Request To Hill For New All-Terrain MRAP Effort
–
ABL Fires High-Powered Laser Through Beam Control For First Time; New ABL Uses Seen
–
Lockheed Martin Gains $1.09 Billion GOES-R Weather Satellite Contract
–
Navy Awards Lockheed Martin $500 Million For Presidential Helicopter Work

Copyright © 2008 Access Intelligence, LLC. All rights reserved.
Reproduction in whole or in part in any form or medium without express written permission of Access Intelligence, LLC is prohibited.